Follow The Filings

TACT TransAct Technologies

TransAct Technologies earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TACT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TACT insider trades
  • $351K bought by 1 insider
  • $4,300 sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. John Dillon CEO
    Buy
    $351K 100,000 shares at $3.51 New stake
    Traded Mar 13–16 Filed Mar 17
    ↗
  2. Steven A Demartino CFO
    Sale
    $4,300 1,000 shares at $4.30 0.7% of stake
    Traded Nov 17, 2025 Filed Nov 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 41 option exercises and 10 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2026 Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13D — Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.07 Filing Doc
10-Q FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2026 Filing Doc
8-K 2.02,5.02,8.01,9.01 Filing Doc
DEF 14A Period May 26, 2026 Filing Doc
DEFA14A — Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2025 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.03,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.